Page 2 - Patrickr Oneil News Today

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has earned an average recommendation of “Hold” from the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. The average […]

Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been given an average rating of “Hold” by the ten analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating on the […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $43.33, but opened at $40.49. Ionis Pharmaceuticals shares last traded at $41.18, with a volume of 334,112 shares changing hands. Wall Street Analyst Weigh In A number of research firms have recently commented […]

Nikko Asset Management Americas Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 336,732 shares of the company’s stock after selling 100,444 shares during the quarter. Nikko […]

Nikko Asset Management Americas Inc. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,732 shares of the company’s stock after selling 100,444 shares during […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. […]

M28 Capital Management LP bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 126,300 shares of the company’s stock, valued at approximately $4,770,000. Ionis Pharmaceuticals makes up 4.5% of M28 Capital Management LP’s holdings, making the stock its 6th largest […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) EVP Patrick R. O’neil sold 1,527 shares of the company’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $41.70, for a total transaction of $63,675.90. Following the sale, the executive vice president now directly owns 40,355 shares in the […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) – Stock analysts at Zacks Research increased their Q1 2023 earnings per share (EPS) estimates for shares of Ionis Pharmaceuticals in a research report issued to clients and investors on Wednesday, April 19th. Zacks Research analyst K. Shah now forecasts that the company will earn ($1.00) per share […]

Sumitomo Mitsui Trust Holdings Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 336,732 shares of the company’s stock after selling 100,444 shares during the period. Sumitomo Mitsui […]